SB4 in the Era of Biosimilars: Clinical Data and Real-World Experience
{{output}}
A biosimilar is a biological medicinal product that is highly similar to an already authorized original biological medicinal product. The introduction of biosimilars may allow for a reduction in health care costs, due to discount pricing. Current clinical stud... ...
